• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT ORTHOPEDICS INC. CONSERVE BFH HEAD 42MM MEDIUM NECK; HIP COMPONENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT ORTHOPEDICS INC. CONSERVE BFH HEAD 42MM MEDIUM NECK; HIP COMPONENT Back to Search Results
Model Number 38014200
Medical Device Problem Codes Corroded (1131); Material Disintegration (1177)
Health Effect - Clinical Code Metal Related Pathology (4530)
Type of Reportable Event Serious Injury
Event or Problem Description
Allegedly, the patient was revised due to metal debris, corrosion and resultant metal ions due to the metal-on-metal design between the articulating surfaces.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONSERVE BFH HEAD 42MM MEDIUM NECK
Common Device Name
HIP COMPONENT
Manufacturer (Section D)
MICROPORT ORTHOPEDICS INC.
5677 airline rd.
arlington TN 38002
MDR Report Key11268519
Report Number3010536692-2021-00052
Device Sequence Number4068822
Product Code KWA
UDI-Device IdentifierM684380142001
UDI-PublicM684380142001
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K021349
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2003
Device Explanted Year2019
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source other
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 02/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number38014200
Device Catalogue Number38014200
Device Lot Number08351687
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date01/12/2021
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/12/2021
Initial Report FDA Received Date02/02/2021
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-